HMI-103

N/A

Report date: 2023/10/26 20:01:00

Base Information

Drug NameHMI-103
Drug Alias NameHMI-103
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsPhenylketonurias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBeckman Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeckman Research InstituteQ32 Bio Inc
Active IndicationsN/A
Inactive IndicationsPhenylketonurias

Other Information

ATC CodeN/A
Related LinksN/A